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The use of drugs during pregnancy still represents a challenge for medicine, since the majority of 
drugs cross the placental barrier with a potential to cause several congenital problems to the fetus, and 
most of them have not been clinically tested in pregnant patients. At the same time, the medicalization 
phenomenon, self-medication, and lack of patient information about the misuse of medicines are 
additional problems. Thus, the aim of this study was to evaluate the pattern of medicine consumption 
in high-risk pregnancies and the determinants related to this consumption pattern. In order to do so, a 
cross-sectional descriptive study was performed with puerperal women who had a history of high-risk 
pregnancy. Statistically significant associations were found between self-medication and fewer prenatal 
visits, and cigarette use during pregnancy and a higher number of children. According to these data, 
the vulnerability of this population to the risks of drug use is evident, demonstrating a gap that requires 
urgent interventions in health-care education.
Uniterms: Medicines/adverse effects. Pregnancy/medicines use. Self-medication. Health education.
O uso de medicamentos na gestação representa, ainda hoje, um desafio para a medicina, visto que grande 
parte dos fármacos atravessa a barreira placentária e, na maioria, não foi testada clinicamente em gestantes, 
podendo vir a ocasionar diversos problemas congênitos ao feto. Ao mesmo tempo, a automedicação, o 
fenômeno da medicalização e a falta de informação sobre os riscos do mau uso de medicamentos são 
problemas adicionais. Diante disto, o objetivo deste estudo consistiu em avaliar o padrão de consumo de 
medicamentos na gestação de alto risco e os determinantes relacionados ao seu padrão de consumo. Para 
tanto, realizou-se um estudo descritivo de corte transversal com puérperas, que apresentaram gestação 
de alto risco. Verificaram-se associações estatisticamente significativas entre automedicação e mulheres 
com menor número de consultas de pré-natal, uso de cigarro na gestação e maior número de filhos. De 
posse destes dados, fica evidente a vulnerabilidade dessa população aos riscos decorrentes do uso de 
medicamentos, sendo esta lacuna um campo de prática com necessidade de intervenções urgentes no 
âmbito da educação em saúde.
Unitermos: Medicamentos/efeitos adversos. Gestação/uso de medicametos. Automedicação. Educação 
em saúde.
INTRODUCTION
The use of medicines during pregnancy still 
represents a challenge for medicine, since the majority of 
drugs cross the placental barrier (Della-Giustina, Chow, 
2003). Despite knowing the selective permeability of the 
placenta, human placental transfer is not well known, 
since the majority of the available information comes 
from experiences in mammals. This limitation in studies 
of drugs in pregnant women is due to ethical and safety 
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reasons, and when there are data on medicines, they are 
from case studies in which the use of such medicine is 
necessary for a better maternal-infant outcome (Cavalli, 
Baraldi, Cunha, 2006).
It is estimated that 10% or more of the congenital 
defects are the result of a previous exposure of the mother 
to drugs (Nakamura, Junior, Pasquale, 2008). In order to 
simplify the evaluation of medicines for pregnant women 
in a practical way, the Food and Drug Administration 
(FDA) classifies drugs in risk categories:
In Category A, the possibility of fetal risk seems to 
be remote; in Category B, there is no controlled study in 
pregnant women, or the studies in animals demonstrating 
effects to the fetus were not confirmed in pregnant women; 
in Category C, there are studies in animals that reveal 
teratogenic effects to the fetus, but there are no available 
studies about the drug in women, thus these drugs must be 
used only if the benefits are higher than the potential risk; 
Category D, there is positive evidence of risk to the human 
fetus, but the benefits of the use during pregnancy are 
acceptable despite the risk; lastly, in Category X the drugs 
are contraindicated due to evidence of fetal abnormalities 
in animals or humans (Department of Health and Human 
Services, 2008).
Besides the risk of using certain medicines, 
modifications in the maternal organism during pregnancy 
may interfere in the extension of fetal exposure to the 
drug administrated to the mother. This effect depends on 
different factors, particularly the mother-fetus elimination 
mechanism and placenta permeability, in addition to the 
reduction of plasmatic carrying proteins and increase 
of cardiac work, which reflects an increased level of 
glomerular filtration and kidney clearance of the drug 
(Morgan, 1997).
Despite the risks imposed on the fetus by the 
utilization of medicines during pregnancy, Carmo 
(2003) describes the current picture of this practice as 
the medicalization of pregnant women. Described by 
Barros (1995), medicalization is a phenomenon seen 
in contemporary society, which is based on elevated 
dependence on medical services and subsequent intensive 
consumption of practices and instruments considered as 
health. Pregnancy medicalization is even more evident in 
the high-risk pregnant woman, because of the passivity 
against something that is possibly adverse, even though it 
is not the case (Gomes et al., 2001).
Another practice to be considered during pregnancy 
is self-medication, which carries a double risk, as it may be 
a risk factor not only to the mother, but to the forming fetus 
as well. Usually, this is done when the woman is seeking 
relief for symptoms caused by physiologic changes that 
occur during this period, when the indiscriminate use of 
drugs is performed in order to combat nausea, anemia, 
pain, and nutritional deficiencies, among others (Mengue 
et al., 2004).
When it comes to high-risk pregnancy, necessary 
attention to the use of medicines is even higher. It 
is indispensable to know the aspects related to the 
consumption of medicines by this group of pregnant 
women, since they show specific characteristics, or suffer 
with some grievance, that represents greater probability of 
unfavorable progression for both fetus and mother.
According to the above, the aim of this work was 
to evaluate the consumption pattern of medicines during 
pregnancy, prescription drugs or self-medication, in 
puerperal women with high-risk pregnancies and the 
determinants related to their consumption pattern. This 
study was carried out at the Maternity of Clinical Hospital 
of the Federal University of Pernambuco (HC/UFPE), 
a reference service in high-risk pregnancy that serves 
pregnant women from several cities of the state, besides 
low-risk pregnant women, admitted during labor.
MATERIAL AND METHODS
A cross-sectional descriptive study was carried out 
and the population consisted of puerperal women admitted 
at Maternity of HC/UFPE, from October to December 
of 2011. The criteria for inclusion in the study were 
giving birth in the hospital and the classification of the 
pregnancy as high-risk according to the criteria presented 
by Technical Manual: High-Risk Pregnancy of Health 
Ministry (Brasil, 2010).
The sample used was proportional with a confidence 
level of 95.0% and a sampling error of 5%. The expected 
frequency used for the calculation was 85.0%, a value 
based on various studies of drug use by pregnant women, 
either high or low risk (Mengue et al., 2004; Melo et al., 
2009; Brum et al., 2011; Guerra et al., 2008). According to 
data collected at the Center for Epidemiology HC / UFPE, 
the average number of births in 2010 was 110 births per 
month, resulting in a population of 330 mothers for the 
three months of data collection, including both low-risk 
and high-risk pregnancies. The estimated value of the 
sample was 123, plus 10% for losses, resulting in a total 
of 136 subjects.
The instrument used for data collection was a 
structured questionnaire that was formulated by the 
researcher. The questionnaire was presented in five 
sections, including questions related to sociodemographic 
data, access to health care services, health and obstetric 
history, prescription drug use, and data related to 
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self-medication. Prior to data collection, a pilot test 
was performed in order to confirm the validity of the 
instrument. The data needed for completing the survey 
were obtained exclusively through answers from 
participants, and with secondary data from medical records 
just to verify that participants fulfilled the inclusion criteria 
for the study (high-risk pregnancy) and confirmation of the 
gestational age at birth.
The processing and analysis of data was performed 
using the statistical package SPSS (Statistical Package 
for the Social Sciences) version 10.0 for Windows, 
initially with the construction of the database and with 
sequential analysis to check for inconsistencies. Next, 
a categorization of continuous variables was made to 
allow implementation of the measures of association 
between exposure and outcome. A description of these 
categorized variables the population was made through 
simple frequencies.
The statistical test performed involved bivariate 
analysis between two categorical variables, measuring the 
association using an odds ratio (OR), for the identification 
of an association between the independent variables 
and the dependent variables (self-medication and more 
drugs used). A confidence interval of 95% and alpha of 
less than 5 were considered statistically significant. The 
independent variables of the study included: age, origin, 
race, marital status, number of children, education, family 
income, number of prenatal visits, gestational age, health 
service used, smoking cigarettes or drinking alcohol 
during pregnancy, history of abortion, and knowledge 
about the risks of drug use during pregnancy.
The research project of this study was approved by 
the Ethics Research Center of Health Sciences, Federal 
University of Pernambuco.
RESULTS AND DISCUSSION
Of the initial sample of 136 subjects, 25 were 
eliminated by exclusion criteria (mostly for low-risk 
pregnancies), 33 refused to participate in the study 
for various reasons, mostly related to limitations in 
the postpartum period, resulting in a total of 78 study 
participants.
The population profile of the puerperal women, 
detailed in Table I, consists mostly of adult women, 
predominantly Brown or Black, residents mainly from 
the metropolitan region of Recife, consisting of 14 cities. 
Most women had a partner, few children, more than 8 
years of school education, and family income above the 
minimum wage.
The analysis of aspects related to health services 
revealed that the entire study population attended at 
least one prenatal consultation (100%), with only 2.6% 
referring distance from the service to their residence. The 
number of medical consultations was predominantly above 
seven (60.3%), with almost all patients using public health 
services for this purpose (98.7%).
Although all participants had access to prenatal 
consultations through SUS (Single Health System), and 
most had attended more than 6 consults as recommended 
by the Program for Humanization of Prenatal and Birth 
instituted by the Ministry of Health (2002), a large 
proportion of pregnant women, 75.6%, also resorted to 
private services, especially ultrasound exams.
Regarding obstetric data, the majority of the studied 
population (64.1%) had a full-term delivery (above 37 
weeks of gestation), with 20.5% of women showing 
abortion antecedents. Tobacco use during pregnancy 
was admitted by 12.8% and alcohol use by 16.7% of the 
puerperal women (Table II).
The values found in this study that were related to 
the use of alcohol and tobacco during pregnancy are higher 
than found in the research of Freire, Padilha and Sauders 
(2009), where only 5.5% of pregnant women reported 
having smoked and 7.4% reported having drank, and these 
practices were related by the authors as strongly associated 
TABLE I – Distribution of the sociodemographic variables 
of puerperal women interned in HC/UFPE after high-risk 
pregnancy, 2011
Variables N %
Age (years)
    10 to 19 
    ≥ 20 
Origin
    Metropolitan region
    Countryside
Race
    Black/Brown/Indigenous
    Caucasian/Asian/Other
Marital status
    With partner 
    Without partner
Number of children
    1 to 2 children
    ≥ 3 children
Education status (years)
    < 8
    ≥ 8 
Family income
    ≤ minimum wage
    > 1 × minimum wage
16
62
44
34
59
19
70
8
60
18
21
57
31
47
20.5
79.5
56.4
43.6
75.6
24.4
89.7
10.3
76.9
23.1
26.9
73.1
39.5
60.3
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with each other, and more related to women who lived 
without a partner and were above 35 years of age.
Regarding drug use, all participants (100%) used at 
least one medicine during pregnancy, either a prescription 
drug or through self-medication, with a mean of 4.6 
drugs per participant, and variation from a minimum of 
1 to a maximum of 11 drugs. Fontoura (2009) reports a 
prevalence similar to the one obtained in our study, where 
98% of the pregnant used some kind of medicine during 
pregnancy. Other authors report a lower prevalence, such 
as 76.4%, 80.1%, and 90% (Oliveira, Fonseca, 2007; Geib 
et al., 2007; Brum et al., 2011).
It is important to consider that the use of medicines 
and the means of medicines used per pregnant woman vary 
considerably in different studies probably due to different 
methodologies applied in the respective studies. In the 
present study, we chose to study the total number of drugs, 
rather than the number of medicines, used by pregnant 
women during gestation. Since many medicines show 
combined formulations containing more than one active 
drug, this study takes into account the risk of exposure to 
each drug.
In this manner, we can infer that the mean number 
of drugs used by the puerperal women in our study is 
greater than the values found in medical literature as a 
consequence of these methodological differences, such as 
TABLE II – Distribution of the variables related to health issues 
during gestation in puerperal women interned in HC/UFPE after 
high-risk pregnancy, 2011
Variables N %
Gestational age at birth (weeks)
     ≤ 37 (preterm)
     > 37 (term)
Previous abortion
     No
     Yes
Smoked during pregnancy
     No
     Yes
Drank alcohol during pregnancy
     No
     Yes
Use of medicines during pregnancy 
(prescription or self-medication)
     No
     Yes
Self-medication
     No
     Yes
28
50
62
16
68
10
65
13
0
78
56
22
35.9
64.1
79.5
20.5
87.2
12.8
83.3
16.7
0,0
100,0
71.8
28.2
the ones observed by Osório de Castro et al. (2004), Guerra 
et al. (2008); Fonseca, Fonseca, Bergsten-Mendes (2002), 
and Brum et al. (2011), where they related means of 2.3; 
2.4; 3; and 4.1 drugs per pregnant woman, respectively. 
Therefore, it is not prudent to relate the higher mean to the 
fact that our patients had high-risk pregnancies.
Regarding the use of prescription drugs by the 
volunteers, it was possible to obtain a mean of 4.2 drugs 
per volunteer, where 61.5% of women consumed from 
1 to 4 drugs and 38.5% used more than 4 drugs during 
pregnancy. The minimal number of medicines used was 
one and the maximum was 11 per patient.
Several authors discuss the utilization of medicines 
during pregnancy as a consequence of a prescriptive 
practice, using also the concept of medicalization during 
pregnancy that, according to Barros (1995), contributes 
to the transformation of normal physiological processes 
into pathological states, such as in pregnancy and 
childbirth. In fact, it is convenient to highlight that an 
irrational prescription of medicines exposes the mother 
and the fetus to avoidable risks. However, an extremely 
conservative posture due to fear of embryo/fetus toxicity, 
in some cases, might lead a woman to unnecessary 
suffering (Fonseca, Fonseca, Bergsten-Mendes, 2002). 
Furthermore, some maternal pathologic situations that 
often result in a high-risk pregnancy should be prioritized 
and pharmacologically treated, under commitment penalty 
of pregnancy and/or generate more risks to the mother and 
to the fetus (Gedeon et al., 2006).
Self-medication during pregnancy was admitted by 
28.2% of patients (Table II), with the quantity varying 
between 1 to 4 medicines, and a mean of 1.4 among 
women that engaged in self-medication. This prevalence 
corroborates the study carried out by Fonseca, Fonseca and 
Bergsten-Mendes (2002), which was of 31.2%. However, 
it was considerably inferior to the one found by Brum et 
al. (2011), where the prevalence of self-medication was 
50% of the studied pregnant women.
The variable related to women’s knowledge about 
the risk of using medicines during pregnancy showed that 
11.5% of patients were unaware of the risk. This result can 
be compared to the one of Melo et al. (2009), with 205 
pregnant women from an antenatal service of the Single 
Health System (SUS), which observed that 19.5% of 
women never received information about the risks of some 
medicines used during pregnancy. The same authors have 
done a comparison with the study performed by Oliveira 
and Fonseca (2007), where 44.4% of women declared 
they were not informed about the risk of drugs used during 
pregnancy. They questioned the need for developing 
educational programs aimed at the minimization of this 
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kind of problem in basic health care services.
The prescription drugs that were used by patients 
during pregnancy and components of the medicines cited 
in the study are shown in Table III according to therapeutic 
class and prevalence of use. The division of the drugs into 
therapeutic classes followed the classification system of 
the Anatomical Therapeutic Chemical (ATC), identified 
by codes. The active substances are divided into different 
groups according to the organ or system on which they 
act and their therapeutic, pharmacological, and chemical 
properties
An important piece of data to be highlighted is that 
20.5% of the women participating in the present study used 
some medicine they did not know the name of, citing only 
its purpose. In the study performed by Osório de Castro et 
al. (2004), 9.3% of the pregnant women could not identify 
the medicine or the active ingredient used, reporting in 
15.5% of the cases use “for pain” and in 12.7% “for urinary 
infection.”
In terms of FDA pregnancy risk category for 
prescription drugs used by patients, the present study 
showed that 14.0% of these drugs belong to risk 
classification A; 37.2% belong to the B class; 39.5% 
belong to the C class, and 9.3% of the drugs belong to risk 
classification D.
Since our study population consisted only of 
puerperal women with high-risk pregnancies, including 
women with previous chronic diseases or who suffered 
some health intercurrence during pregnancy, the use of 
D class medicines was expected, as these were drugs in 
which the benefits of use overcome the potential risks to 
the fetus. However, the percentage of drugs that belonged 
to D class was small, when compared to the percentages 
of B and C class drugs used in the study.
According to Geib et al. (2007), the use of class A 
medicines is associated with prenatal attention, reinforcing 
the prevention of gestational and fetal damage, since this 
class contains antianemics and vitamins. Drugs that belong 
to B, C, and D classes have their consumption associated 
with intercurrences of health in pregnancy, having the B 
class a consumption adequacy; the C class with biological 
factors related to history of abortion and caesarean; and 
the D class lower consumption in the economic classes 
less favored.
TABLE III – Distribution of prescribed drugs during gestation, according to the Anatomical Therapeutic Chemical Classification 
System (ATC), used by puerperal women interned in HC / UFPE after high-risk pregnancy, 2011
Therapeutic classes (ATC code) N % Drugs
Antianemic preparations (B03)
    Iron Preparations (B03A)
    Vitamin B12 and Folic acid (B03B)
Vitamins (A11)
Analgesics (N02)
Corticosteroids for systemic use (H02)
Antibacterials for systemic use (J01)
Gynecological antiinfectives and antiseptics (G01)
 
Antiprotozoals (P01)
Antifungals for dermatological use (D01) 
Antimycotics for systemic use (J02)
Drugs for functional gastrointestinal disorders (A03)
Drugs for acid related disorders (A02)
Antihistamines for systemic use (R06)
Cardiovascular system (C)
Immunosuppressants (L04)
Antiepileptics (N03)
Psycholeptics (N05)
Drugs for obstructive airway diseases (R03)
Sex hormones and modulators of the genital system (G03)
75
69
48
17
45
2
22
20
1
1
1
13
9
17
14
1
1
2
1
2
96.2
88.5
61.5
21.8
57.7
2.6
28.2
25.6
1.3
1.3
1.3
16.7
11.5
21.8
17.9
1.3
1.3
2.6
1.3
2.6
ferrous sulfate, ferric hydroxide
folic acid
multivitamins, vitamin C, B complex
dipyrone, paracetamol
betamethasone, prednisone
amoxicillin, ampicillin, benzathine 
benzylpenicillin, cefalexin, cefuroxime-axetil, 
ciprofloxacin, norfloxacin 
amphotericin B, clindamycin, metronidazole, 
miconazole nitrate, nystatin, tetracyclin
tinidazole 
ketoconazole
fluconazole
bromopride, butylscopolamine bromide, 
metoclopramide, 
aluminum hydroxide, omeprazole
dimenhydrinate, promethazine, 
dexchlorpheniramine, meclizine 
atenolol, enalapril, methyldopa
azathioprine
lamotrigine
haloperidol
budesonide 
progesterone
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Table IV shows the drugs according to their 
therapeutic classes and prevalence of use, and components 
of medicines participants reported consuming through 
self-medication. Self-medication with analgesics and 
antipyretics by a considerable portion of the women was 
comparable to values found by other authors (Fonseca, 
Fonseca, Bergsten-Mendes, 2002; Brum et al., 2011; 
Guerra et al., 2008). Among analgesics, paracetamol is 
considered a safe drug for use in pregnancy and belongs 
in FDA category B, while dipyrone and aspirin belong to 
the risk category C.
Self-medication in this study also involved the 
consumption of anti-inflammatory drugs classified as fetal 
risk categories C or D, depending on gestational age. Anti-
inflammatory, non-steroidal medicines are commonly used 
by pregnant women for painful conditions including back 
pain, urinary tract infection, and hemorrhoids, among 
others. However, use of this class of drugs is associated 
with the possibility of fetal cardiac abnormalities (Lopes, 
Francisco, Zugaib, 2010).
One patient reported the use of misoprostol for 
abortion, which is classified as category X by the FDA. 
This drug is a prostaglandin indicated for the treatment of 
gastric ulcer, banned for sale in the country for consumers, 
due to its contraindication during pregnancy since it is 
capable of inducing spontaneous incomplete abortion, 
with the possibility of causing bleeding and need for 
curettage (Osório-de-Castro et al., 2004).
In regard to the execution of treatment using 
prescription drugs during pregnancy, it was found that all 
users of continuous use drugs, such as immunosuppressants, 
antiepileptics, and antipsychotics, completed the treatment 
without interruption during pregnancy. Among users of 
antihypertensives, only 14.3% did not follow the complete 
treatment according to the prescribed posology.
In the case of antimicrobials, results showed that 
40.9% of patients who used antibacterials for systemic 
use during pregnancy did not complete the treatment and 
30.0% of woman who used gynecological antiinfectives 
and antiseptics did not complete the treatment as 
prescribed. These data are alarming, since it reflects the 
great number of pregnant women who are not properly 
executing their treatment with antimicrobials, and who are 
exposing themselves beyond susceptibility to microbial 
resistance, to infection exacerbations.
A considerable amount of antibiotics used by 
study participants were indicated due to urinary tract 
infections (UTI). The inadequate treatment reveled in 
the study exposes the women to complications of UTI, 
such as urinary obstruction, preterm labor, premature 
amniorrhexis, chorioamnionitis, endometritis, and other 
complications. This also exposes the fetus to risk, making 
it more vulnerable to premature birth, secondary infection, 
and even death (Duarte et al., 2008).
In bivariate analyses related to the consumption 
of more drugs (above the mean of 4 for the study), 
associations were not verified to be statistically significant 
with the independent variables of this study.
The results of bivariate analyses verified a probability 
approximately two times higher for performing self-
medication in the following categories: adult women 
(above 19 years old), women with family income lower 
than one times the minimum wage, and women without 
obstetric history of abortion. However, these associations 
are not considered statistically significant (Table V).
The associations regarding self-medication which 
were statistically significant, described in Table V, 
demonstrate a greater chance of this practice in women 
who had fewer prenatal visits (six or less), those who 
smoked during pregnancy, and women with three or more 
children.
Another point to be emphasized is the association 
TABLE IV – Distribution of drugs used for self-medication during gestation, according to the Anatomical Therapeutic Chemical 
Classification System (ATC), used by puerperal women interned in HC / UFPE after high-risk pregnancy, 2011
Therapeutic classes (ATC code) N % Drugs
Analgesics (N02)
Antiinflammatory and antirheumatic products (M01)
Vitamins (A11)
Muscle relaxants (M03)
Antihistamines for systemic use (R06)
Expectorants (R05C)
Throat preparations (R02)
Nasal preparations (R01)
Oxytocics (G02A)
16
 
3
2
1
1
1
2
2
1
20.5
 
3.9
2.6
1.3
1.3
1.3
2.6
2.6
1.3
acetylsalicylic acid, dipyrone, paracetamol
diclofenac sodium, diclofenac potassium, 
mefenamic acid 
multivitamins, vitamin C
orphenadrine
dimenhydrinate
carbocisteine
benzalkonium
naphazoline
misoprostol
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between the number of prenatal consultations and self-
medication. In this case, the pregnant women already have 
an aggravating factor, which is the inadequacy of their 
obstetric follow-up, and are exposed to the risk of using 
substances without medical supervision. This doubles 
their risks.
The association between self-medication and tobacco 
use is worrying since smoking may increase drug potential 
TABLE V – Prevalence of self-medication during gestation by study variables in puerperal women interned in HC / UFPE after 
high-risk pregnancy, 2011
Variables
Use of medicines without prescription (self-medication)
No Yes OR
(95% CI)(n) (%) (n) (%)
Age (years)
     10 to 19 
     ≥ 20
Origin
     Countryside
     Metropolitan region
Race
     Caucasian/Asian/Other
     Black/Brown/Indigenous
Marital Status 
     With partner
     Without partner
Number of children
     1 to 2 
     ≥ 3 
Educational status (years of study)
     ≥ 8 
     < 8 
Family Income
     > 1 minimum wage
     ≤ 1 minimum wage
Number of prenatal consultations
     ≥ 7
     < 7
Gestational age (weeks)
     ≤ 37 (preterm) 
     > 37 (term)
Health services
     Only SUS
     SUS and private
Smoked
     No 
     Yes
Drank alcohol
     No
     Yes
Previous abortion
     Yes
     No
Know the risk of drug use in pregnancy
     Yes
     No
13
43
25
31
15
41
50
6
47
9
43
13
37
19
39
17
17
39
13
43
52
4
47
9
13
43
49
7
81.25
69.35
73.53
70.45
78.95
69.49
71.43
75.00
78.33
50.00
75.44
61.90
78.72
61.29
82.98
54.84
60.71
78.00
72.22
71.67
76.47
40.00
72.31
69.23
81.25
69.35
71.01
77.78
3
19
9
13
4
18
20
2
13
9
14
8
10
12
8
14
11
11
5
17
16
6
18
4
3
19
20
2
18.75
30.65
26.47
29.55
21.05
30.51
28.57
25.00
21.67
50.00
24.56
38.40
21.28
38.71
17.02
45.16
39.29
22.00
27.78
28.33
23.53
60.00
27.69
30.77
18.75
30.65
28.99
22.22
1
1.92 (0.49–7.51)
1
1.17 (0.43–3.17)
1
1.65 (0.48–5.66)
1
0.83 (0.15–4.48)
1
3.62 (1.19–10.96)
1
1.89 (0.65–5.50)
1
2.34 (0.86–6.39)
1
4.02 (1.42–11.34)
1
0.44 (0.16–1.20)
1
1.03 (0.32–3.33)
1
4.88 (1.22–19.45)
1
1.16 (0.32–4.25)
1
1.92 (0.49–7.51)
1
0.70 (0.13–3.66)
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for teratogenesis. This occurs because the cigarette smoke 
consists of a mixture of numerous inductors and inhibitors 
of P450 substrates, and thus, is capable of modifying drug 
clearance or endogenous metabolism (Nakamura, Junior, 
Pasquale, 2008; Czekaj et al., 2005).
The positive association between self-medication 
and a greater number of children found in this study 
corroborates the study of Guerra et al. (2008), where a 
statistically significant association was verified between 
self-medication and multiparous women. A reason for this 
association was not found in medical literature; however, 
we speculate that multiparous women have a higher 
tendency for self-medication due to their experience of 
using medicines during previous pregnancies, and their 
assumption that medicines will not cause problems in the 
current pregnancies.
The present study found some limitations to its 
execution: (1) the possibility of recall bias, due to the 
need to remember medication used since the beginning 
of pregnancy, (2) the possibility of omission of questions 
about self-medication, (3) the inherent particularities of 
the postpartum period, which, in some cases, have become 
obstacles to data collection.
CONCLUSIONS
Considering that the study was performed only with 
puerperal women with high-risk pregnancies, the average 
drug consumption did not differ from other works with 
pregnant women in general. Despite the small number 
of women unaware of drug use risks during pregnancy, 
the practice of self-medication still exists, even with 
access to health care units. Self-medication was related to 
pregnant women with lower number of antenatal visits and 
smokers, requiring special attention to this group in order 
to discourage this habit, not only because of the damage 
smoking can cause to the fetus, but also because of its 
potential to increase the teratogenic power of other drugs.
 Based on the reported data, vulnerability of this 
population of women to the risks from the use of drugs is 
evident, and this is a gap in the field of practice that needs 
urgent intervention by way of health education. Also in this 
context, the need of the pharmacist in primary health care 
units is highlighted, in order to ensure the rational use of 
medicines during pregnancy, with a consequent reduction 
of problems due to medicine misuse.
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